Related Experiment Videos
Vasoseal after intra-aortic balloon pump removal: a pilot study.
H L Chadow1, R E Hauptman, B Strizik
1Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, NY 11212, USA. hlcmd@aol.com
Summary
A vascular hemostasis device (VHD) offers a safe and effective method for achieving hemostasis after intra-aortic balloon pump (IABP) removal. This study found no bleeding or vascular complications in patients using the VHD.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Surgery
Background:
- Vascular complications occur in up to 15% of patients following intra-aortic balloon pump (IABP) removal.
- Vascular hemostasis devices (VHDs) are established for post-cardiac catheterization hemostasis.
Purpose of the Study:
- To evaluate the safety and efficacy of a VHD for achieving hemostasis after IABP removal.
- To assess the feasibility of VHD deployment without a guidewire during IABP removal.
Main Methods:
- A prospective study involving 10 patients undergoing IABP removal.
- Utilized a VHD (Vasoseal) for achieving hemostasis post-IABP removal.
- Primary endpoint: composite of bleeding, infection, and vascular complications at 7 days; secondary endpoint: time to hemostasis.
Main Results:
- No instances of bleeding, infection, or vascular injury were observed at the 7-day follow-up.
- The mean time to achieve hemostasis was 12.9 minutes, with a range of 8–17 minutes.
Conclusions:
- The VHD can be safely and effectively utilized for hemostasis after IABP removal.
- This approach minimizes the risk of vascular complications associated with IABP withdrawal.